Strome SE - Search Results

1

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. Dong H, et al. Among authors: strome se. Nat Med. 2002 Aug;8(8):793-800. doi: 10.1038/nm730. Epub 2002 Jun 24. Nat Med. 2002. PMID: 12091876

2

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.

Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, Chapoval AI, Strome SE, Pease LR, Chen L. Wilcox RA, et al. Among authors: strome se. J Clin Invest. 2002 Mar;109(5):651-9. doi: 10.1172/JCI14184. J Clin Invest. 2002. PMID: 11877473 Free PMC article.

3

Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.

Wilcox RA, Tamada K, Strome SE, Chen L. Wilcox RA, et al. Among authors: strome se. J Immunol. 2002 Oct 15;169(8):4230-6. doi: 10.4049/jimmunol.169.8.4230. J Immunol. 2002. PMID: 12370353

4

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis.

Dong H, Strome SE, Matteson EL, Moder KG, Flies DB, Zhu G, Tamura H, Driscoll CL, Chen L. Dong H, et al. Among authors: strome se. J Clin Invest. 2003 Feb;111(3):363-70. doi: 10.1172/JCI16015. J Clin Invest. 2003. PMID: 12569162 Free PMC article.

5

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, Salomao D, Cheville J, Hirano F, Lin W, Kasperbauer JL, Ballman KV, Chen L. Strome SE, et al. Cancer Res. 2003 Oct 1;63(19):6501-5. Cancer Res. 2003. PMID: 14559843

6

Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.

Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, Lau JS, Zhu Y, Flies DB, Tamada K, Chen L. Choi IH, et al. Among authors: strome se. J Immunol. 2003 Nov 1;171(9):4650-4. doi: 10.4049/jimmunol.171.9.4650. J Immunol. 2003. PMID: 14568939

7

Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients.

Strome SE, Martin E, Flies D, Khurana D, Salomao D, Tamada K, Chapoval AI, Kasperbauer JL, Olsen KD, Chen L. Strome SE, et al. Otolaryngol Head Neck Surg. 2002 Feb;126(2):180-7. doi: 10.1067/mhn.2002.122263. Otolaryngol Head Neck Surg. 2002. PMID: 11870350

8

Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L. Strome SE, et al. Cancer Res. 2002 Mar 15;62(6):1884-9. Cancer Res. 2002. PMID: 11912169

9

Costimulation-based immunotherapy for head and neck cancer.

Strome SE, Chen L. Strome SE, et al. Curr Treat Options Oncol. 2004 Feb;5(1):27-33. doi: 10.1007/s11864-004-0003-9. Curr Treat Options Oncol. 2004. PMID: 14697154 Review.

10

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. Thompson RH, et al. Among authors: strome se. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17174-9. doi: 10.1073/pnas.0406351101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569934 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page